Chad, BDRR News Out
Bederra Corporation Considers Digital Mammography Services
Bederra Corporation (PINKSHEETS: BDRR), a medical imaging and diagnostic Company, begins initial due diligence into offering Digital Mammography Services.
The company is looking into the feasibility of creating a Women's Breast Imaging Center within its current facilities. Currently there is a backlog for Mammography services in the greater Houston, Texas area. Most Mammography centers are located within Hospitals and not outpatient facilities, making it more inconvenient for patients. This creates potential for the company to increase revenue for its other imaging services by attracting a larger group of referring physicians.
Digital Mammography offers a faster and more accurate stereotactic biopsy. This results in faster examination times and patient comfort. The resulting images allow the radiologist to have greater flexibility and accuracy in reading the images. This latest technology can be implemented with relative ease and due to the large available backlog the company can diversify its revenue stream by adding this additional medical imaging service for its clients.
About Bederra Corporation
Bederra Corporation, which wholly owns Diagnos, Inc. and Lumar Imaging, Inc., provides multiple modality diagnostic medical imaging services to the greater Houston area and world famous Texas medical center. The company's current strategy is to grow its current operations and seek out additional acquisitions that will complement its core operations.
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact:
Chad Sykes
Investor Relations
Email Contact
